Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The villains were injectable specialty drugs like Keytruda and inpatient surgical procedures for seriously ill patients.

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CI stock, giving a Buy rating yesterday.Invest with Confidence: ...

Ladies, and gentlemen, thank you for standing by for the Cigna Group fourth-quarter 2024 results review. (Operator Instructions) As a reminder, ladies and gentlemen, this conference, including the Q&A ...

The Cigna Group ( NYSE:CI) delivered full-year revenue growth of 27% to approximately $247 billion in 2024. Full-year ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

A handful of people turned out to comment on plans to convert a former motel property in West Brattleboro into a residential ...

Thank you for standing by for the Cigna Group's fourth quarter 2024 results review. At this time, all callers are in a listen ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...